Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

Rigel shaken after fostamatinib misses phase III trial target

RigelFirm will still pursue early 2017 FDA approval for the autoimmune disease therapy

From: Marketing

UDG Healthcare acquires STEM Marketing for £84m

UDG HealthcareAims to expand its Ashfield service offering

From: Regulatory

Lilly snags first approval for sarcoma drug Lartruvo

Eli Lilly HQGranted accelerated approval by the FDA becoming first front-line STS therapy for 40 years

From: Regulatory

NICE U-turn on Opdivo for kidney cancer

Bristol-Myers Squibb (BMS) buildingBMS sways the watchdog with new data and a patient access scheme


Pharmaceutical Market Europe - October 2016

There’s no shortage of ambition at GlaxoSmithKline, whose chief immunology officer and senior vice president of their R&D pipeline Paul-Peter Tak we spoke to for this month’s executive interview.

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Dominic Tyer

Have your say...

Immunocore appoints chief financial officer

Paul Fry brings leadership experience from GlaxoSmithKline


A balanced multichannel communications process

Uncover the customer experience and reflect it in your strategy

Complete HealthVizion Richard White

Pricing's dodos

Mylan isn’t alone in its outdated practices

darwins medicine

Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. We are an award-winning agency with over 30...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...